B. Riley Securities Reiterates Buy on Wave Life Sciences, Lowers Price Target to $18
Benzinga Newsdesk 18 hours ago
Analyst RatingsNewsReiterationPrice Target
B. Riley Securities analyst Madison El-Saadi reiterates Wave Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $22 to $18.
B. Riley Securities analyst Madison El-Saadi reiterates Wave Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $22 to $18.